A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC
Clinical trial NCT05378867 · UNKNOWN
Trial details
- NCT number
- NCT05378867
- Sponsor
- Zhejiang Teruisi Pharmaceutical Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-10-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.